2024 U.S.-Booked Air Volume: $72 million
2024 Global Booked Air Volume: $155 million
Primary Airline Suppliers: American, Delta, United
Primary Global Online Booking Tool: SAP Concur
Primary Global Expense Supplier: SAP Concur
Primary Global Payment Supplier: American Express
Primary Global Travel Risk Management Supplier: ISOS
Consolidated Global TMC: Amex GBT
Medtronic expects to return to pre-pandemic travel spend levels in the next couple of years, and U.S.-booked air volume climbed to $72 million in 2024 from $66.2 million in 2023. The company has a consolidated global travel policy, with 91 percent of U.S-booked spend (of which 89 percent is for domestic travel) routed through preferred booking tools.
Employee count at the medical device manufacturer remained constant for the third year running at 95,000, spread across 150 countries. Revenue rose 4 percent year over year to $33.5 billion in the fiscal year to April 25, 2025. During that year, Medtronic had 170 active clinical trials and gained 130 regulatory approvals. The company spent $2.7 billion on research and development.
Business travel emissions jumped from 123,000 metric tons of carbon dioxide equivalent in 2023 to 154,000 in 2024, out of a total of 3.2 million tons of Scope 3 emissions.